Sebastian Conner-Rilk

Sebastian Conner-Rilk

Auto-generated profile, based on publicly available information

Sebastian Conner-Rilk

Department of Orthopaedic Surgery Hospital for Special Surgery, NewYork‐Presbyterian, Weill Medical College of Cornell University New York New York USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2024 in Knee Surgery, Sports Traumatology, Arthroscopy
Verified
Journal Article
Open access
SRSebastian Rilk
Sebastian Rilk
GGGabriel C. Goodhart
Gabriel C. Goodhart
JLJelle P. van der List
Jelle P. van der List
FRFidelius Von Rehlingen‐Prinz
Fidelius Von Rehlingen‐Prinz
HVHarmen D. Vermeijden
Harmen D. Vermeijden
GDGregory S. DiFelice
Gregory S. DiFelice
Purpose: To evaluate the impact of age as a risk factor on the revision rates of anterior cruciate ligament (ACL) primary repair (ACLPR), dynamic intraligamentary stabilization (DIS) and bridge‐enhanced ACL restoration (BEAR) compared to ACL reconstruction (ACLR).Methods: A systematic literature search was performed for comparative studies comparing outcomes for ACLPR, DIS or BEAR to ACLR. A random‐effects meta‐analysis was performed to assess nondifferentiated and age‐differentiated (skeletally mature patients ≤21 and >21 years) ACL revision and reoperation risk, as well as results for subjective outcomes. Methodological study quality was assessed using the Risk of Bias Tool 2.0c and Methodological Index for Nonrandomized Studies tools.Results: A total of 12 studies (n = 1277) were included. ACLR demonstrated a lower nonage‐stratified revision risk at 2 years versus ACLPR, DIS and BEAR, but a similar revision risk at 5 years when compared to DIS. However, an age‐stratified analysis demonstrated a significantly increased ACLPR revision risk as compared to ACLR in skeletally mature patients ≤21 years of age (risk ratios [RR], 6.33; 95% confidence interval [CI], 1.18–33.87, p = 0.03), while adults (>21 years) showed no significant difference between groups (RR, 1.48; 95% CI, 0.25–8.91, n.s.). Furthermore, DIS reoperation rates were significantly higher than respective ACLR rates (RR, 2.22; 95% CI, 1.35–3.65, p = 0.002), whereas BEAR (RR, 1.07; 95% CI, 0.41–2.75, n.s.) and ACLPR (RR, 0.81; 95% CI, 0.21–3.09, n.s.) showed no differences. IKDC scores were equivalent for all techniques. However, ACLPR exhibited significantly better FJS (mean difference, 11.93; 95% CI, 6.36–17.51, p < 0.0001) and Knee injury and Osteoarthritis Outcome Score Symptoms (mean difference, 3.01; 95% CI, 0.42–5.60, p = 0.02), along with a lower Tegner activity reduction.Conclusions: ACLPR in skeletally mature patients ≤21 years of age is associated with up to a six‐fold risk increase for ACL revision surgery compared to ACLR; however, adults (>21 years) present no significant difference. Based on the current data, age emerges as a crucial risk factor and should be considered when deciding on the appropriate treatment option in proximal ACL tears.Level of Evidence: Level III.

5 April 2023 in Journal of ISAKOS
Verified
Journal Article
Open access
SRSebastian Rilk
Sebastian Rilk
ASAdnan Saithna
Adnan Saithna
AAAndrea Achtnich
Andrea Achtnich
AFAndrea Ferretti
Andrea Ferretti
BSBertrand Sonnery-Cottet
Bertrand Sonnery-Cottet
GDGregory S. DiFelice
Gregory S. DiFelice

23 May 2025 in The American Journal of Sports Medicine
Verified
Journal Article
Closed access
SCSebastian Conner-Rilk
Sebastian Conner-Rilk
GGGabriel C. Goodhart
Gabriel C. Goodhart
FRFidelius von Rehlingen-Prinz
Fidelius von Rehlingen-Prinz
JLJelle P. van der List
Jelle P. van der List
KKKyle N. Kunze
Kyle N. Kunze
GDGregory S. DiFelice
Gregory S. DiFelice
Background: Primary anterior cruciate ligament (ACL) repair (ACLPR) demonstrates promising short-term clinical outcomes in select patients; however, it remains poorly understood as to whether previously reported short-term outcomes are maintained at midterm follow-up. Purpose: To determine whether short-term (2-year) outcomes are maintained at 5 years after ACLPR, evaluate age-stratified failure and reoperation rates, and identify preoperative risk factors for failure. Study Design: Case series; Level of evidence, 4. Methods: This prospective study included the first 113 consecutive patients with proximal (type I/II) ACL tears who underwent ACLPR between 2008 and 2017 with a minimum 5-year follow-up. Failure rates were recorded based on instrumented laxity (>3-mm anterior tibial translation side-to-side difference), pivot-shift grade (grade ≥2), and subjective instability. Patient Acceptable Symptom State thresholds were established based on collected patient-reported outcome measure scores. Logistic regression models were constructed to determine associations with independent risk factors for failure. Results: A total of 107 patients (median age, 35.5 years [interquartile range, 22.4-43.1 years]) were available at final follow-up (median, 6.0 years [interquartile range, 5.3-7.0 years]). No significant differences were reported in failure rates between 2- and 5-year follow-up: overall non–age-differentiated: 11.5% versus 15.9%, respectively ( P = .34); ≤21 years: 37.0% versus 38.5%, respectively ( P = .92); and >21 years: 3.5% versus 8.6%, respectively ( P = .16). No failures occurred in patients aged ≤21 years, while 4 failures occurred in patients aged >21 years. Additionally, no significant differences were observed in overall non–age-differentiated reoperation rates (6.2% vs 7.5%, respectively; P = .71) and contralateral ACL injury rates (3.5% vs 4.7%, respectively; P = .67). Clinical outcomes and patient-reported outcome measure scores did not significantly differ between time points, and most patients met Patient Acceptable Symptom State thresholds (88% for International Knee Documentation Committee form, 91% for Lysholm scale, 93% for Forgotten Joint Score–12, and 84% for ACL–Return to Sport after Injury scale; all P < .001). Preoperative risk factor analysis only revealed younger age as negatively impacting ipsilateral ACL failure, as the odds decreased by 12.5% for each year of increasing age ( P = .002). Conclusion: Sustained clinical and functional outcomes for ACLPR were observed between short-term and midterm follow-up, with failure rates of 11.5% and 15.9%, respectively. Although younger age was an important risk factor for ipsilateral ACL failure, with a high failure rate of 37.0% in patients aged ≤21 years at short-term follow-up, no additional failures were observed at midterm follow-up. In contrast, patients aged >21 years experienced modest failure rates, increasing from 3.5% at short-term follow-up to 8.6% at midterm follow-up, with no significant change.

26 December 2025 in Knee Surgery, Sports Traumatology, Arthroscopy
Verified
Journal Article
Closed access
MMMaximilian M. Mueller
Maximilian M. Mueller
Craig E. KlingerCraig E. Klinger
Craig E. Klinger
SCSebastian Conner‐Rilk
Sebastian Conner‐Rilk
JWJerry Wang
Jerry Wang
KSKevin G. Shea
Kevin G. Shea
DGDaniel W. Green
Daniel W. Green

7 May 2026 in Orthopaedic Journal of Sports Medicine
Verified
Journal Article
Open access
JSJakob Schanda
Jakob Schanda
FTFabian Maximilian Tomanek
Fabian Maximilian Tomanek
SCSebastian Conner-Rilk
Sebastian Conner-Rilk
PHPhilipp Richard Heuberer
Philipp Richard Heuberer
ULUlrich Lanz
Ulrich Lanz
Background: Despite technical advancements, recurrent glenohumeral joint instability after surgical treatment is still a major issue. Challenging conventional arthroscopic Bankart repair, the labral bridge technique provides an even labral compression to the glenoid rim, potentially enabling anatomic healing and lasting stability. Purpose: To evaluate clinical outcomes after arthroscopic Bankart repair using the labral bridge technique at a short-term follow-up. Study Design: Case series; Level of evidence, 4. Methods: Patients aged 18 to 50 years with traumatic first-time or recurrent shoulder dislocation treated with the arthroscopic labral bridge technique and an early motion rehabilitation protocol were consecutively included. Exclusion criteria were concomitant fractures, bony defects >10%, multidirectional shoulder instability, previous shoulder surgery, epilepsy, or chronic alcohol or drug abuse. Postoperative shoulder stability was assessed using the Rowe score. Patient-reported outcome measures, including the American Shoulder and Elbow Surgeons (ASES) score, Single Assessment Numeric Evaluation (SANE), and Visual Analog Scale (VAS) for pain were evaluated preoperatively and after a minimum of 2 years. Results: A total of 46 patients (mean age, 28.9 ± 9.0 years) were included. At the final follow-up (mean, 35.8 ± 10.3 months), 2 patients (4.3%) experienced a recurrent traumatic anterior dislocation. The Rowe score improved significantly with lasting stability compared to preoperative levels (mean, 93.0 ± 16.7 postoperatively vs 37.8 ± 15.2 preoperatively; P < .001). Except for a significant improvement in forward flexion by 10.5° ( P = .013), no differences in postoperative range of motion were observed compared to preoperative levels. The ASES score, SANE, and VAS for pain improved significantly compared to preoperative levels (all P < .001). The minimal clinically important difference was reached by 92.7% of patients for the Rowe score, 92.9% for the ASES score, 83.3% for the SANE, and 73.8% for the VAS for pain. The patient acceptable symptom state was achieved by 92.9% of patients for the ASES score, 83.3% for the SANE, and 97.6% for the VAS for pain. Conclusion: Arthroscopic Bankart repair with the labral bridge technique for the treatment of anterior shoulder instability demonstrates a low recurrent shoulder instability rate and significant improvements in clinical and functional outcomes at a minimum follow-up of 2 years.

2 August 2023 in Journal of ISAKOS
Verified
Journal Article
Open access
PDF file
SRSebastian Rilk
Sebastian Rilk
HVHarmen D. Vermeijden
Harmen D. Vermeijden
JLJelle P. van der List
Jelle P. van der List
GDGregory S. DiFelice
Gregory S. DiFelice
G.S.D. is on the speakers bureau of Arthrex.